USPTO 2015–2025 USPTO PatentsView US Corporation

Seattle Genetics, Inc.

USPTO PatentsView assignee record - 71 granted patents across 13 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

19.9

Avg claims per patent

-85%

5-year filing velocity

The verdict

Seattle holds 71 US patents across 13 technology areas, rank #4,911 of 50,000 tracked assignees.

#4,911
of 50,000 US assignees by volume: Top 37%
by Innovation Score (39.7/100): 19.9
avg claims per patent: -85%
filing velocity, last 5 yrs

Portfolio overview

Seattle Genetics, Inc. has been granted 71 US utility patents between 2015 and 2023, placing Seattle Genetics, Inc. at rank #4,911 across all assignees tracked by PlainPatent. This portfolio spans 13 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Seattle Genetics, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Seattle sits between Pro-iroda Industries, Inc. (71 patents, rank #4,907) and Schul International Co., Llc (71 patents, rank #4,915) - the closest US assignees by grant volume. The composite Innovation Score of 39.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 62 in the 2015–2019 window, a -85% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Seattle Genetics, Inc.'s 19.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 13 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Seattle Genetics, Inc. against peers pursuing similar technology classes.

Pro-iroda Industr…

71
Proxense

71
Pukyong National…

71
Satake

71
Sekisui Plastics

71
SR

71
Staubli Faverges

71
Schul Internation…

71
Seattle Genetics ◀

71

What this shows Seattle holds 71 patents at rank #4,911, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seattle

By rank, the assignees closest to #4,911 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Seattle's primary technology class.

Seattle's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Seattle Genetics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	14.1%
2016	16	22.5%
2017	13	18.3%
2018	9	12.7%
2019	14	19.7%
2020	7	9.9%
2021	1	1.4%
2023	1	1.4%

Which technologies does Seattle Genetics, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 63

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 60

C07K - PEPTIDES 55

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 21

C07D - HETEROCYCLIC COMPOUNDS 13

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 5

B01D - SEPARATION 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1

Top 13 of 13 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#4,911

Across all tracked assignees

Innovation Score

39.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Seattle Genetics, Inc. hold?

Seattle Genetics, Inc. holds 71 US granted patents filed between 2015 and 2023, spanning 13 technology areas.

What is Seattle Genetics, Inc.'s Innovation Score?

Seattle Genetics, Inc. has an Innovation Score of 39.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Seattle Genetics, Inc. focus on?

Seattle Genetics, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 63 patents. The company has filed patents in 13 CPC subclasses total.

Is Seattle Genetics, Inc.'s patent filing rate increasing or decreasing?

Seattle Genetics, Inc.'s recent filing velocity is -85% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Seattle Genetics, Inc.'s patents?

Seattle Genetics, Inc.'s patents average 19.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Seattle Genetics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Seattle's 71 grants land it in the top 37% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Seattle ranks #4,911 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.